Isolated human genes would be patentable, and the costs of medical diagnostic tests would jump under a recently introduced bill to revamp patent eligibility, panelists at an American Civil Liberties Union virtual briefing said Monday—a stance that former patent officials labeled “scaremongering.”
Patents for Human Genes, Diagnostic Tests Generate Policy Debate Read More »
It’s no secret that the film industry looks different than it did when I worked in Hollywood decades ago. Gone are the days when eager movie-goers’ only option was to pile into theaters to watch the latest hit. Today, many Americans can enjoy watching films from the comfort of their own homes. The way we
Intellectual property rights are the heroes of America’s innovation story Read More »
Medicare has a herculean task ahead of setting up an infrastructure to take on an entirely new function for the program — regulating how much it pays for certain medications, and penalizing drug makers that hike prices faster than inflation. With new responsibility comes new bureaucracy, new documents obtained by STAT show.
New high-level lobby group will promote role of IP in US innovation Read More »
Medicare has a herculean task ahead of setting up an infrastructure to take on an entirely new function for the program — regulating how much it pays for certain medications, and penalizing drug makers that hike prices faster than inflation. With new responsibility comes new bureaucracy, new documents obtained by STAT show.
Medicare has a herculean task ahead of setting up an infrastructure to take on an entirely new function for the program — regulating how much it pays for certain medications, and penalizing drug makers that hike prices faster than inflation. With new responsibility comes new bureaucracy, new documents obtained by STAT show.
Bipartisan Group Aims To Halt ‘Downward’ Slide Of IP System Read More »
On Wednesday, September 28, more than 100 friends of the Council for Innovation Promotion gathered to celebrate its launch. Distinguished guests included Sen. Chris Coons (D-DE), Sen. Thom Tillis (R-NC), and Rep. Thomas Massie (R-KY). Our honored guests offered remarks at the event along with C4IP’s co-chairs, Andrei Iancu and David Kappos, and C4IP’s two
Celebrating the Launch of the Council for Innovation Promotion Read More »
Medicare has a herculean task ahead of setting up an infrastructure to take on an entirely new function for the program — regulating how much it pays for certain medications, and penalizing drug makers that hike prices faster than inflation. With new responsibility comes new bureaucracy, new documents obtained by STAT show.
The next frontier of the drug pricing fight Read More »
Medicare has a herculean task ahead of setting up an infrastructure to take on an entirely new function for the program — regulating how much it pays for certain medications, and penalizing drug makers that hike prices faster than inflation. With new responsibility comes new bureaucracy, new documents obtained by STAT show.
Coons Announces He Will Co-Sponsor Tillis’ Patent Eligibility Restoration Act Read More »
Medicare has a herculean task ahead of setting up an infrastructure to take on an entirely new function for the program — regulating how much it pays for certain medications, and penalizing drug makers that hike prices faster than inflation. With new responsibility comes new bureaucracy, new documents obtained by STAT show.
Medicare has a herculean task ahead of setting up an infrastructure to take on an entirely new function for the program — regulating how much it pays for certain medications, and penalizing drug makers that hike prices faster than inflation. With new responsibility comes new bureaucracy, new documents obtained by STAT show.
Medicare has a herculean task ahead of setting up an infrastructure to take on an entirely new function for the program — regulating how much it pays for certain medications, and penalizing drug makers that hike prices faster than inflation. With new responsibility comes new bureaucracy, new documents obtained by STAT show.
